Josh Brown Pitches Best AI Stock ‘Not a Lot of People Know About’

We recently published Top 10 Trending Stock Ratings and Calls as Tom Lee Says Latest Selloff is a Buying Opportunity. Veeva Systems Inc. (NYSE:VEEV) is one of the top trending stock ratings and calls.

Josh Brown from CNBC recently talked about why he added VEEV to his best stock ideas list. Veeva Systems provides cloud-based software for the life sciences industry. Brown talked about the company’s AI angle and CRM solution for pharma companies:

“It’s this incredible company. Basically, every time you hear a pharmaceutical or a biotech CEO extolling the virtues of what AI is going to do for their business, they’re probably excited because they’re working with Veeva Systems. Veeva is effectively becoming the industry standard CRM platform for drug discovery. They’ve signed some of the biggest companies in healthcare, Bristol Myers recently. They’ve got a product called Vault CRM. What’s changed with this company over the last couple of years, and the reason why it’s rallying so hard, is they used to have a system that was built on top of Salesforce itself. They’ve spent a ton of money in capex to build their own system, their own Vault CRM.”

Brown thinks that the company’s fundamentals are strong and operating margins “look great” after the company made its own platform.

“This year is going to be the company’s most profitable year in absolute dollar terms back to 2020. They’ve made this huge investment, built out their own product, and are signing large deals with some of the biggest companies in pharma and biotech. Again, it’s a stock that not a lot of people know about while they increase market share. It’s not a cheap stock, nor should it be.”

TimesSquare Capital U.S. Focus Growth Strategy stated the following regarding Veeva Systems Inc. (NYSE:VEEV) in its second quarter 2025 investor letter:

“The strategy received a 24% boost from Veeva Systems Inc. (NYSE:VEEV) which offers cloud-based systems for the life sciences industries, from R&D to commercialization. Veeva’s revenues and earnings bested expectations with some of the strongest dollar-value results in the company’s history. Commercial subscription revenue growth accelerated, driven by Veeva’s Crossix platform that provides anonymized data analytics for health care marketing. Veeva also recently announced new AI-embedded features for its Vault suite of customer relationship management applications.”

While we acknowledge the risk and potential of VEEV as an investment, our conviction lies in the belief that some AI stocks hold greater promise for delivering higher returns and doing so within a shorter time frame. If you are looking for an AI stock that is more promising than VEEV and that has 10,000% upside potential, check out our report about this cheapest AI stock.

READ NEXT: 30 Stocks That Should Double in 3 Years and 11 Hidden AI Stocks to Buy Right Now.

Disclosure: None. This article is originally published at Insider Monkey.